Company Search:
Advanced Search
Sponsored Links
Molmed S.P.A. Company Snapshot
Molmed S.P.A. operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Molmed S.P.A. with three other miscellaneous service companies in Europe: Veloxis Pharmaceuticals A/S of Denmark (2017 sales of 196.99 million Danish Kroner [US$29.90 million] of which 100% was Pharmaceutical Preparations), Eurofins-Cerep SA of France (24.41 million Euro [US$27.64 million] ), and Brain Biotechnology Research and Information Network AG which is based in Germany (26.42 million Euro [US$29.91 million] of which 51% was BioIndustrial).

Sales Analysis. Molmed S.P.A. reported sales of 23.00 million Euro (US$26.05 million) for the year ending December of 2017. This represents an increase of 18.0% versus 2016, when the company's sales were 19.48 million Euro. Sales at Molmed S.P.A. have increased during each of the previous five years (and since 2012, sales have increased a total of 401%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Molmed S.P.A.
  Stock Performance Chart for Molmed S.P.A.
  Stock Data: Recent Stock Performance:
  Current Price (2/8/2019): .29
(Figures in Euro)
1 Week 1.6%   13 Weeks 4.8%  
4 Weeks -4.8%   52 Weeks -46.1%  
Molmed S.P.A. Key Data:
  Ticker: MLM Country: Italy
  Exchanges: ISE Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 23,000,000
(Year Ending Jan 2018).
Employees: 185
  Currency: Euro Market Cap: 132,778,618
  Fiscal Yr Ends: December Shares Outstanding: 463,450,672
  Share Type: Azioni Ordinaire Closely Held Shares: 146,856,240
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.